Latest Breaking News On - Frederic pouliot - Page 1 : comparemela.com

Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels

Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseySan franciscoMelissa downsseniorHospitalier universitaireMark kinarneyviceFrederic pouliotAmerican society of clinical oncologyCorporate communicationsLantheus holdings incClinical oncologyGenitourinary cancers symposiumJean claude provostChief medical officerImage misinterpretationimagingFull prescribing

EAU 2021: Is Nuclear Medicine Taking over the Treatment of Metastatic Prostate Cancer? PRLT Is Only a Tessera in the Treatment of CRPC

EAU 2021: Is Nuclear Medicine Taking over the Treatment of Metastatic Prostate Cancer? PRLT Is Only a Tessera in the Treatment of CRPC
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United statesZachary klaassenFrederic pouliotEuropean association of urologyGeorgia cancer centerCanadian urological associationAugusta university medical college of georgiaEuropean associationAnnual meetingUniversite lavalQuebec universite lavalQuebec cityUrologic oncologistAssistant professorMedical collegeஒன்றுபட்டது மாநிலங்களில்

PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions

PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United statesNew yorkAnn arborYale schoolUniversity of iowaStanford universityWashington universitySan franciscoIowa citySierra madreUniversity of pennsylvaniaMemorial sloan kettering cancer centerUniversity of wisconsinNew havenMichael morrisNancy stambler

Clinical Application and Utility of PyLARIFY (18F DCFPyL) in Prostate Cancer

UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.

United statesSan franciscoPrestonc sprenkleJeremyc durackMichaelj morrisFrederic pouliotProgenics pharmaceuticals incLocalized prostate cancerIndividualizing diagnosisProgenics pharmaceuticalsஒன்றுபட்டது மாநிலங்களில்சான் பிரான்சிஸ்கோஃப்ரெடரிக் போஉலிஓத்

Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting

Press release content from Business Wire. The AP news staff was not involved in its creation. Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting February 4, 2021 GMT NORTH BILLERICA, Mass. (BUSINESS WIRE) Feb 4, 2021 Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced today three abstracts featuring its PSMA-targeted pipeline of product candidates have been selected for poster presentations at the upcoming 2021 American Society for Clinical Oncology Genitourinary (ASCO GU) Virtual Meeting, which will be held from February 11-13, 2021. Two of the abstracts relate to PyL™, the Company’s PET/CT imaging agent for prostate cancer, and the third abstract relate

New yorkUnited statesMemorial sloan kettering cancer centerNew jerseyNorth billericaJeremyc durackFrederic pouliotMark kinarneyOliver sartorBausch health companies incCentre hospitalier universitaireProgenics pharmaceuticals incTulane cancer centerLantheus medical imaging incCorporate communicationsLantheus holdings inc